Singapore - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Singapore Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 6.6% year on year. In 2019, the country was ranked number 219 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 22 Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 22.00 |
| 2018 | 21.00 |
| 2017 | 20.00 |
| 2016 | 23.00 |
| 2015 | 13.00 |
Download all data from 2005 to 2019
How does Singapore rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 219 |
#219
Mauritania
|
22 | 2019 | -12.0 % | +22.4 % | View data | |
| 219 |
#219
Singapore
|
22 | 2019 | +4.8 % | +6.6 % | View data | |
| 223 |
#223
El Salvador
|
21 | 2019 | +250.0 % | +7.0 % | View data | |